Rayonier Advanced Materials Inc. (RYAM) · Nov 3, 2026 · Earnings

RYAM earnings miss as tariffs deepen losses and delay review

Miss — EPS $(3.40) vs roughly $0.02–$0.10 consensus; revenue $383M vs roughly $386M–$389M

RYAM earnings missed expectations as tariff-driven Temiscaming losses and impairments overwhelmed improving Cellulose Specialties performance. The strategic review now runs into Q1 2027.

RYAM is trying to shift its business toward higher-value Cellulose Specialties while containing losses in its commodity paperboard and high-yield pulp operations. Before this release, management had been targeting a conclusion to its strategic review in the fourth quarter of 2026 and expected sequential improvement in the second half of the year. The quarter missed the market’s operating expectation by a wide margin. Net sales of $383 million were below published estimates clustered around $386 million to $389 million, while diluted EPS was a $3.40 loss against expectations for roughly breakeven. The miss was not just a small earnings variance: the quarter included $221 million of non-cash impairments, including $210 million tied to the Paperboard & High Yield Pulp segment.

Q3 2026Q3 2025Consensus
Net sales (Income Statement)$383M (-)$353M~$386M–$389M
Diluted EPS (Income Statement)$(3.40)$(0.07)~$0.02–$0.10
Adjusted EBITDA (Segment results)$52M (+24%)$42M
Adjusted free cash flow (Cash Flow statement)$2M$(103)M

The specialty-cellulose engine is improving, but it is not yet large enough to carry the company. High Purity Cellulose operating income rose to $43 million from $38 million a year earlier, and its adjusted EBITDA reached $73 million versus $64 million. Cellulose Specialties volume was lower year over year, but its average selling price increased to $2,227 per metric ton from $1,873, supporting the strategic pivot. Those gains were overwhelmed by Paperboard & High Yield Pulp, which produced a $224 million operating loss versus a $14 million loss last year. 〔0〕

The tariff shock has converted a weak segment into an immediate restructuring problem. The 50% U.S. tariff on Canadian paperboard made continued production at Temiscaming uneconomic, leading to an economic idling on October 3, 2026 and ongoing carrying costs of $2 million to $3 million per month. That makes the company’s strategic review more urgent, but also harder: potential buyers or partners now need to assess an idled site rather than a functioning operation. 〔1〕

The strategic timetable slipped at exactly the wrong moment. RYAM now targets completion in the first quarter of 2027, replacing the prior fourth-quarter 2026 target. The delay is not merely administrative; management says interested parties need greater clarity on Temiscaming’s path forward, while the company continues discussing alternatives to strengthen Cellulose Specialties more quickly. 〔2〕

Cash generation improved, but the balance sheet still leaves little room for prolonged weakness. Year-to-date adjusted free cash flow was barely positive at $2 million, global liquidity was $143 million, and adjusted net debt remained $745 million despite lower total debt. Stockholders’ equity moved to a $35 million deficit from $317 million of positive equity at year-end, reflecting the scale of the impairment burden.

Bottom line: The specialty-cellulose turnaround is making real progress, but this filing shows the rest of RYAM is deteriorating faster than that progress can offset. The earnings miss, tariff-driven idling, heavy impairments and delayed strategic review materially weaken the near-term business story.

What to watch next

Strategic review conclusion, Q1 2027

Original filing on SEC EDGAR

RYAM earnings miss as tariffs deepen losses and delay review | RYAM Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.